New combination treatment overcomes resistance in ER positive breast cancer

[News]

In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have tested a new combination therapy for hormone-resistant, estrogen receptor-positive (ER+) breast cancer and were able to shrink tumors, reduce the number of cancer stem cells and reprogram the immune environment to be less supportive of cancer growth.

More... (https://www.news-medical.net/news/20251106/New-combination-treatment-overcomes-resistance-in-ER-positive-breast-cancer.aspx)